Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ReSchedule Med
AddedFeb 18, 2024
UpdatedJul 3, 2026
ReSchedule Med

ReSchedule Med

Closed

Streamlining medical residency scheduling with Reschedule's end-to-end solution.

HQ
New York City, NY, US
Founded
2014
Accelerator
Y Combinator logoY CombinatorW15
Overview
Compare
Fundraising
Employees

ReSchedule Med's core mission is to streamline the scheduling process for medical residency programs, addressing one of the largest logistical pain points in hospitals. The company offers an end-to-end workflow solution designed to manage graduate medical education scheduling efficiently. Their market focus is on medical institutions and residency programs that require robust scheduling tools.

ReSchedule Med has significantly impacted the medical education sector by simplifying complex scheduling tasks, thereby improving operational efficiency in hospitals. Their innovative approach has garnered attention and support within the healthcare community, positioning them as a key player in medical residency logistics.

ReSchedule Med - Similar Companies

Untether Labs logo

Untether Labs

untetherlabs.com

Durate logo

Durate

durate.com

Mederva Health logo

Mederva Health

medervahealth.com

Shift Health logo

Shift Health

shifthealth.io

CaseCTRL logo

CaseCTRL

casectrl.com

Gradia Health logo

Gradia Health

gradia.com

AgileMD logo

AgileMD

agilemd.com

CadenceMD logo

CadenceMD

DirectShifts logo

DirectShifts

directshifts.com

ShiftDoc logo

ShiftDoc

Thalamus logo

Thalamus

thalamusgme.com

Certainly Health logo

Certainly Health

Medtrics Lab logo

Medtrics Lab

medtricslab.com

Simbie AI logo

Simbie AI

simbie.ai

Ezdoctor logo

Ezdoctor

ReSchedule Med - Quick Facts

Who are ReSchedule Med's competitors?

Companies similar to ReSchedule Med include Untether Labs, Durate, Mederva Health and Shift Health.

When was ReSchedule Med founded?

ReSchedule Med was founded in 2014.

Where is ReSchedule Med's headquarters located?

ReSchedule Med's headquarters is located in New York City, NY, US.

When was ReSchedule Med's last funding round?

ReSchedule Med's most recent funding round was for $120k (USD) in March 2015.

How much has ReSchedule Med raised to-date?

As of Mar 22, 2015, ReSchedule Med has raised a total of $120k (USD).

ReSchedule Med - Classification

Ownership
  • Venture Capital
Technology
  • SaaS
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Tags
  • Healthcare
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8060Hospitals